All sessions are noted in Eastern Time Zone. Please adjust to your time zone accordingly
Sponsored by Novo Nordisk
Explore efficacy and safety data for 2 GLP-1 RA options for adults with T2D. A review of data from pivotal glycemic control trials as well as cardiovascular outcomes trial data will be presented.